A new study published by Cleveland Clinic researchers in Diabetes, Obesity and Metabolism investigating the genetic ...

If you’ve been taking Ozempic or Wegovy (both of which contain the active ingredient semaglutide), you might wonder, How long ...

Table of Contents The Real Story Behind Your Changing Body Making Every Bite Count When You’re Eating Less Your Brain […] The ...

Some health experts view GLP-1s as a promising option for PCOS, which lacks a standard treatment and affects millions of ...

Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a ...

Semaglutide, also known by the brand names Ozempic and Wegovy, is quickly becoming a popular weight-loss medication. (Getty Images) Like nearly 50% of Americans, Talia (not her real name) had ...

Among patients receiving semaglutide for obesity management, the risk for muscle loss may be higher in older adults and women ...

Older age and female sex may be associated with greater muscle loss in adults with obesity prescribed semaglutide.

Novo Nordisk is in the lead, but not alone. Obesity doctors say they are gearing up for demand, predicted to be high. Some ...

On April 29, 2025, Hims & Hers and Novo Nordisk unveiled a landmark collaboration to bring Wegovy—Novo's blockbuster ...

Semaglutide has been described as a "game changer" for treating obesity and was FDA-approved for weight loss in 2021 under the brand name Wegovy. It's also available as Ozempic, which is the same ...

Semaglutide, a weight-loss drug, showed promise for treating obesity in recent research. Demand quickly exceeded supply after the FDA in June approved once-weekly semaglutide injections.